(Q34303192)

1 August 2017

1 reference

title

VEGF as a mediator of tumor-associated immunodeficiency (English)

1 reference

1 August 2017

Ohm JE

1

1 reference

PubMed ID

11444391

1 August 2017

Carbone DP

series ordinal

2

1 reference

1 August 2017

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

23

1 reference

1 August 2017

263-272

1 reference

1 August 2017

2-3

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:23:2-3:263

1 August 2017

0 references

cites work

Antigen-presenting activity of draining lymph node cells from mice painted with a contact allergen during ultraviolet carcinogenesis

1 reference

12 December 2020

Clinical significance of the determination of angiogenic factors

1 reference

12 December 2020

NF-kappaB activation: the I kappaB kinase revealed?

1 reference

12 December 2020

Tumor-induced immune dysfunction

1 reference

12 December 2020

Immunologic nonresponsiveness to tumors

1 reference

12 December 2020

Tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

Function and activation of NF-kappa B in the immune system

1 reference

12 December 2020

The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation

1 reference

12 December 2020

Toward a genetic analysis of tumor rejection antigens.

1 reference

12 December 2020

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

1 reference

12 December 2020

Identification of genes encoding T cell defined tum- antigens

1 reference

12 December 2020

Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor

1 reference

12 December 2020

Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function

1 reference

12 December 2020

Where have all the T cells gone? Mechanisms of immune evasion by tumors

1 reference

12 December 2020

1 reference

12 December 2020

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

12 December 2020

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells

1 reference

12 December 2020

KDR receptor: a key marker defining hematopoietic stem cells

1 reference

12 December 2020

Escape from host-antitumor immunity.

1 reference

12 December 2020

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

12 December 2020

Angiogenesis and metastasis

1 reference

12 December 2020

The biology of vascular endothelial growth factor

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.

1 reference

12 December 2020

NF-kappa B: ten years after

1 reference

12 December 2020

New insights into the roles of ReL/NF-kappa B transcription factors in immune function, hemopoiesis and human disease

1 reference

12 December 2020

Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses

1 reference

12 December 2020

Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells

1 reference

12 December 2020

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

12 December 2020

Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation

1 reference

12 December 2020

Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer.

1 reference

12 December 2020

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

1 reference

12 December 2020

The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients

1 reference

12 December 2020

Immunologic dysfunction in cancer

1 reference

12 December 2020

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

12 December 2020

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

12 December 2020

NF-kappa B: a lesson in family values

1 reference

12 December 2020

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

12 December 2020

Human tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma

1 reference

12 December 2020

Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors

1 reference

12 December 2020

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

12 December 2020

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:23:2-3:263

1 reference

PubMed ID

11444391

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11444391